APA (7th ed.) Citation

CT, N., T, S., CE, M., S, T., & PB, J. (2026). Cost-effectiveness of Taurolidine as secondary prevention of recurrent catheter-related bloodstream infections in patients with chronic intestinal failure: Findings from a randomized controlled trial. Clinical nutrition (Edinburgh, Scotland), 62, 106694. https://doi.org/10.1016/j.clnu.2026.106694

Chicago Style (17th ed.) Citation

CT, Nerstrøm, Scheike T, Moser CE, Tribler S, and Jeppesen PB. "Cost-effectiveness of Taurolidine as Secondary Prevention of Recurrent Catheter-related Bloodstream Infections in Patients with Chronic Intestinal Failure: Findings from a Randomized Controlled Trial." Clinical Nutrition (Edinburgh, Scotland) 62 (2026): 106694. https://doi.org/10.1016/j.clnu.2026.106694.

MLA (9th ed.) Citation

CT, Nerstrøm, et al. "Cost-effectiveness of Taurolidine as Secondary Prevention of Recurrent Catheter-related Bloodstream Infections in Patients with Chronic Intestinal Failure: Findings from a Randomized Controlled Trial." Clinical Nutrition (Edinburgh, Scotland), vol. 62, 2026, p. 106694, https://doi.org/10.1016/j.clnu.2026.106694.